Hypermutation In Pancreatic Cancer - Gastroenterology
Current Treatment Landscape and Emerging Therapies for Pancreatic Cancer
Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications | Gut
PDF) Study of Microsatellites Role in BRCA2 Gene Causing Pancreatic Cancer and Breast Cancer | P. Anuradha and Prof. Ravi Shankar Nowpada - Academia.edu
Diagnostics | Free Full-Text | The Utility of Endoscopic-Ultrasonography-Guided Tissue Acquisition for Solid Pancreatic Lesions | HTML
High-depth, high-accuracy microsatellite genotyping enables precision lung cancer risk classification | Oncogene
Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology in: Journal of the National Comprehensive Cancer Network Volume 19 Issue 4 (2021)
Pembrolizumab in microsatellite instability high or mismatch repair deficient cancers: updated analysis from the phase II KEYNOTE-158 study - Annals of Oncology
Cancer prevention and screening: the next step in the era of precision medicine | npj Precision Oncology
Current Treatment Landscape and Emerging Therapies for Pancreatic Cancer
Frontiers | Research Progress of Biomarkers for Immune Checkpoint Inhibitors on Digestive System Cancers
Irrelevance of Microsatellite Instability in the Epidemiology of Sporadic Pancreatic Ductal Adenocarcinoma
Frequency of mismatch repair deficiency in pancreatic ductal adenocarcinoma - ScienceDirect
Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial - The Lancet Oncology
Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology in: Journal of the National Comprehensive Cancer Network Volume 19 Issue 4 (2021)
Emerging molecular markers of cancer | Nature Reviews Cancer
Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial - The Lancet Oncology
Clinical Applications of Classical and Novel Biological Markers of Pancreatic Cancer
Cancers | Free Full-Text | Clinical Applications of Classical and Novel Biological Markers of Pancreatic Cancer | HTML
Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma | Nature Genetics
Frontiers | Molecular and Computational Methods for the Detection of Microsatellite Instability in Cancer
Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Tar
Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular patholo
Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology in: Journal of the National Comprehensive Cancer Network Volume 19 Issue 4 (2021)
Cancers | Free Full-Text | Genetic Alterations Featuring Biological Models to Tailor Clinical Management of Pancreatic Cancer Patients | HTML
Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial - The Lancet Oncology
PDF) Diagnostic, Predictive and Prognostic Molecular Biomarkers in Pancreatic Cancer: An Overview for Clinicians
Irrelevance of Microsatellite Instability in the Epidemiology of Sporadic Pancreatic Ductal Adenocarcinoma | PLOS ONE
